The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Invitae
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
 
Alberto Carretero-González
No Relationships to Disclose
 
Daniel Kwon
No Relationships to Disclose
 
Nonna Shakhnazaryan
No Relationships to Disclose
 
Julian C. Hong
Research Funding - Roche (Inst)
 
Osama Mohamad
Research Funding - Salesforce; Salesforce
 
Mary Uan-Sian Feng
Leadership - Artera (I)
Stock and Other Ownership Interests - Artera (I); Bluestar Genomics (I); Serimmune (I)
Consulting or Advisory Role - AstraZeneca; Bayer (I); Blue Earth Diagnostics (I); BMS (I); Exact Sciences (I); Foundation Medicine (I); Janssen Oncology (I); Novartis (I); POINT Biopharma (I); POINT Biopharma (I); SerImmune (I); Tempus (I); Varian Medical Systems (I)
Research Funding - AstraZeneca (Inst); Varian Medical Systems (Inst); Zenith Epigenetics (I)
Patents, Royalties, Other Intellectual Property - Helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, his employer at the time. It is in the process of being licensed to PFS Genomics, a company he helped fou (I); UpToDate
 
Ivan de Kouchkovsky
Consulting or Advisory Role - Janssen
 
Hala Borno
Employment - Collective Health (I); Trial Library; Waymark (I)
Leadership - Collective Health (I); Trial Library; Trial Library; Waymark (I)
Stock and Other Ownership Interests - Collective Health (I); Trial Library; Waymark (I)
Honoraria - AstraZeneca; BMS; ConcertAI; Dendreon
Consulting or Advisory Role - AstraZeneca; BMS; Dendreon
 
Rohit Bose
Honoraria - Janssen; Qessential Medical Marketing Research; Tegus
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Atara Biotherapeutics (I); Bluebird Bio (I); Celgene (I); Exelixis (I)
Consulting or Advisory Role - Exai Bio
Research Funding - Amgen (Inst)
 
Arpita Desai
Consulting or Advisory Role - Dendreon; Exelixis; Janssen Oncology; Merck
 
Lawrence Fong
Stock and Other Ownership Interests - Actym Therapeutics; Alector; Atreca; BioAtla; Bolt Biotherapeutics; ImmunoGenesis; NGM Biopharmaceuticals; Nutcracker Therapeutics, Inc.; RAPT Therapeutics; Senti Biosciences; Sutro Biopharma
Consulting or Advisory Role - Actym Therapeutics; AstraZeneca; Atreca; BioAtla; Bolt Biotherapeutics; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Dendreon; EMD Serono; ImmunoGenesis; Innovent Biologics; Janssen Oncology; Merck; NGM Biopharmaceuticals; Nutcracker Therapeutics, Inc.; RAPT Therapeutics; Roche/Genentech
Research Funding - Abbvie (Inst); Amgen (Inst); Bavarian Nordic (Inst); Dendreon (Inst); Merck (Inst)
 
Terence W. Friedlander
Leadership - Med BioGene
Honoraria - Astellas Pharma; Astellas Scientific and Medical Affairs Inc; AstraZeneca/MedImmune; EMD Serono
Consulting or Advisory Role - AADi; Astellas Pharma; Basilea; Dava Oncology; EMD Serono; Foundation Medicine; Merck; Seagen; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca/MedImmune; Genentech/Roche; Jounce Therapeutics
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte (Inst); Merck (Inst); Nektar (Inst); Taiho Oncology (Inst)
 
Felix Y Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Rahul Raj Aggarwal
Consulting or Advisory Role - Advanced Accelerator Applications; Alessa Therapeutics; Amgen; Bayer; Dendreon; Exelixis; Jubilant Pharmaceuticals; Merck; OncLive.; OncLive.; Pfizer; Tersera
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Thomas A. Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Lantheus Medical Imaging (Inst); Philips Healthcare (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson and Johnson
Consulting or Advisory Role - Fortis; Janssen Oncology; Teon Therapeutics